Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Fecal microbiota transplantation (FMT) is highly effective against recurrent Clostridioides difficile infection and is considered a promising treatment for other microbiome-related disorders, but a comprehensive understanding of microbial engraftment dynamics is lacking, which prevents informed applications of this therapeutic approach. Here, we performed an integrated shotgun metagenomic systematic meta-analysis of new and publicly available stool microbiomes collected from 226 triads of donors, pre-FMT recipients and post-FMT recipients across eight different disease types. By leveraging improved metagenomic strain-profiling to infer strain sharing, we found that recipients with higher donor strain engraftment were more likely to experience clinical success after FMT ( P = 0.017) when evaluated across studies. Considering all cohorts, increased engraftment was noted in individuals receiving FMT from multiple routes (for example, both via capsules and colonoscopy during the same treatment) as well as in antibiotic-treated recipients with infectious diseases compared with antibiotic-naïve patients with noncommunicable diseases. Bacteroidetes and Actinobacteria species (including Bifidobacteria ) displayed higher engraftment than Firmicutes except for six under-characterized Firmicutes species. Cross-dataset machine learning predicted the presence or absence of species in the post-FMT recipient at 0.77 average AUROC in leave-one-dataset-out evaluation, and highlighted the relevance of microbial abundance, prevalence and taxonomy to infer post-FMT species presence. By exploring the dynamics of microbiome engraftment after FMT and their association with clinical variables, our study uncovered species-specific engraftment patterns and presented machine learning models able to predict donors that might optimize post-FMT specific microbiome characteristics for disease-targeted FMT protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, combined routes of FMT administration are an effective strategy to enhance strain engraftment.747”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [747]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, although a family or household member donor was found associated with higher strain sharing at baseline, this did not result in higher strain engraftment rates once prior strain sharing was considered. 75”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With this approach, microbial engraftment has been associated with clinical success, regardless of disease, in a large metagenomic metanalysis of 24 FMT trials and almost 1,400 fecal samples. 75”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the infusion of a healthy microbiome is clinically effective regardless of its composition in rCDI, the composition of donor microbial communities appears to play a key role in treating noncommunicable disorders, 56 likely mediated by the achievement of successful microbial engraftment. 75”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [75]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Notably, FMT using combined routes was associated with a higher likelihood of microbial engraftment than single-route infusion in a metagenomic metanalysis of 24 studies. 75”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [75]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0686-2 · Cited by 38,430
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Fast and sensitive protein alignment using DIAMOND
Buchfink, B., Xie, C., & Huson, D. H. (2015) · Nature Methods · doi:10.1038/nmeth.3176 · Cited by 14,201
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2019) · Apollo - University of Cambridge Repository · doi:10.17863/cam.64134 · Cited by 10,460
Li, D., Liu, C.-M., Luo, R., Sadakane, K., & Lam, T.-W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv033 · Cited by 9,893
Cited by
Blanco-Míguez, A., Beghini, F., Cumbo, F., McIver, L. J., Thompson, K. N., Zolfo, M., Manghi, P., Dubois, L., Huang, K. D., Thomas, A. M., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01688-w · Cited by 1,442
“StrainPhlAn 4 also allows the analysis of strain sharing and transmission between communities 4,25,28,73,77–79 for uncharacterized species, that is, uSGBs (see Methods).”
BackgroundSelf-citationShort-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
Fusco, W., Lorenzo, M. B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M. C., Gasbarrini, A., Collado, M. C., et al. (2023) · Nutrients · doi:10.3390/nu15092211 · Cited by 1,243
Self-citationMicrobiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Routy, B., Lenehan, J. G., Miller, W. H., Jamal, R., Messaoudene, M., Daisley, B. A., Hes, C., Al, K. F., Martinez-Gili, L., Punčochář, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02453-x · Cited by 526
Self-citation
Metadata
- Authors
- Ianiro, G., Punčochář, M., Karcher, N., Porcari, S., Armanini, F., Asnicar, F., Beghini, F., Blanco-Míguez, A., Cumbo, F., Manghi, P., Pinto, F., Masucci, L., Quaranta, G., De Giorgi, S., Sciumè, G. D., Bibbò, S., Del Chierico, F., Putignani, L., Sanguinetti, M., Gasbarrini, A., Valles-Colomer, M., Cammarota, G., & Segata, N.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- University of Trento (IT)
- Bambino Gesù Children's Hospital (IT)
- Corresponding author
- Ianiro, Gianluca
- Segata, Nicola
- ORCID
- Ianiro, Gianluca
- Punčochář, Michal
- Karcher, Nicolai
- Porcari, Serena
- Armanini, Federica
- Asnicar, Francesco
- Beghini, Francesco
- Blanco-Míguez, Aitor
- Cumbo, Fabio
- Manghi, Paolo
- Pinto, Federica
- Masucci, Luca
- Quaranta, Gianluca
- De Giorgi, Silvia
- Sciumè, Giusi Desirè
- Bibbò, Stefano
- Putignani, Lorenza
- Sanguinetti, Maurizio
- Gasbarrini, Antonio
- Valles-Colomer, Mireia
- Cammarota, Giovanni
- Segata, Nicola
- Venue
- Nature Medicine
- Published
- 2022-09
- Volume
- 28
- Issue
- 9
- Pages
- 1913-1923
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC9499858
- OpenAlex
- W4295925800
- Cited by
- 366
- References
- 89
- Citations by year
- 2026: 92 · 2025: 119 · 2024: 84 · 2023: 67 · 2022: 3
- FWCI
- 22.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 14 d)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Iris (University of Trento) (submittedVersion, cc-by)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
- Funders
- Ospedale Pediatrico Bambino Gesù
- Ministero della Salute (2018-, GR-2018-12365734, “5×1000”)
- Ministero dell’Istruzione, dell’Università e della Ricerca (H2020, RBFR13EWWI_001)
- Università degli Studi di Trento
- Fondazione Roma
- National Institutes of Health (1u01ca230551-01a1, H2020, 1U01CA230551)
- Horizon 2020 Framework Programme (OncoBiome 825410, 818368, ONCOBIOME-825410 project, MASTER-818368 project, 825410)
- National Cancer Institute (1U01CA230551, U01 CA230551)
- H2020 European Research Council (716575)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, microbiota composition, Clostridium difficile infection, Bifidobacterium, Bacteroidetes, actinobacteria, Firmicutes, donor selection, antibiotic therapy, non-communicable diseases
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Anti-Bacterial Agents, Clostridium Infections, Feces, Humans, Treatment Outcome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. https://app.cochat.ai/papers/10.1038/s41591-022-01964-3
- The paper
- Ianiro, G., Punčochář, M., Karcher, N., Porcari, S., Armanini, F., Asnicar, F., Beghini, F., Blanco-Míguez, A., Cumbo, F., Manghi, P., Pinto, F., Masucci, L., Quaranta, G., De Giorgi, S., Sciumè, G. D., Bibbò, S., Del Chierico, F., Putignani, L., Sanguinetti, M., . . . Segata, N. (2022). Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nature Medicine. https://doi.org/10.1038/s41591-022-01964-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.